Detalhe da pesquisa
1.
IL-12 and IL-27 Promote CD39 Expression on CD8+ T Cells and Differentially Regulate the CD39+CD8+ T Cell Phenotype.
J Immunol
; 210(10): 1598-1606, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37000461
2.
Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memory.
Mol Ther
; 31(2): 535-551, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068918
3.
Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma.
Cancer Immunol Immunother
; 72(5): 1247-1260, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396738
4.
CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity.
Eur J Immunol
; 50(5): 695-704, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943150
5.
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Nat Med
; 29(8): 2121-2132, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414899
6.
Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Nat Med
; 30(2): 604, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37923839
7.
ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.
DNA Cell Biol
; 27(5): 229-40, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18358073
8.
TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.
Clin Cancer Res
; 23(4): 1068-1079, 2017 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856600
9.
Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalan.
Tumori
; 102(1): 31-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26429639
10.
Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2.
Oncotarget
; 7(15): 20825-39, 2016 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26959114
11.
Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.
J Clin Oncol
; 22(9): 1646-54, 2004 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15117987
12.
Local and systemic toxicity of h-R3, an anti-epidermal growth factor receptor monoclonal antibody, labeled with 188osmiun after the intracerebral administration in rats.
Exp Toxicol Pathol
; 56(4-5): 313-9, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15816360
13.
IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells.
PLoS One
; 10(11): e0143435, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26579709
14.
siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine.
Oncotarget
; 6(26): 22397-409, 2015 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26087398
15.
Imaging tumor growth non-invasively using expression of MagA or modified ferritin subunits to augment intracellular contrast for repetitive MRI.
Mol Imaging Biol
; 16(1): 63-73, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23836502
16.
Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin.
Oncotarget
; 5(9): 2778-91, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24784564
17.
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.
Mol Oncol
; 8(8): 1429-40, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24974076
18.
Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality".
Mol Ther Nucleic Acids
; 2: e78, 2013 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23481354
19.
Magnetic resonance imaging of cells overexpressing MagA, an endogenous contrast agent for live cell imaging.
Mol Imaging
; 8(3): 129-39, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19723470